1. Lawes CM, Hoorn SV Rodgers A.

Global burden of bloodpressu re-related disease,

2001. Lancet 2008;371 :1 5 1 3- 1 5 1 B.

2. Lim SS, Gaziano TA, Gakidou E, et al. Prevention of cardiovascular disease in high-risk
individuals in low-income and middle-income countries; Health effects and costs. Lancet
2007;370:20542064.

3. Kaplan NM. Measurement of Blood Pressure. In: Kaplan's Clinical Hvpertension. Eds:
Kaplan NM, Victor RG, Flynn JT. 10s ed. Philadelphia: Lippincott Williams and
Wilkins, 2010; p 20-47.

4. Cooper RS, Bamidele T. Geographic patterns of hypertension: Global perspective. ln:

Hypertension Primer. Eds: lzzo )L, Sica DA, Black HR. 4th ed. Dallas: Lippincott
Williams & Wilkins,2008;p 239-240.

5. Yogiantoro M. Hipertensi Essential. Dalam: Buku Ajar Ilmu Penyakit Dalam. Eds:
Sudoyo AW, Setiyohadi B, Alwi I, Simadibrata M, Setiati S. edisi V. Jakarta:
InternaPublishing, 201,0;p1079-1083.

6. Hard PD Bakris GL. Primary (Essential) hypertension. ln: Current diagnosis and
treatment. Nephrology and hypertension. Eds: Lerma EV Berns JS, Nissenson AR. New
York: Mc Rraw Hill, 2009; p 353-358.

7. 11. Kaplan NM. Primary Hypertension: Patogenesis. ln: Kaplan's Clinical Hypertension.
Eds: Kaplan NM, Victor RG, Flynn JT. 1Oth ed. Philadelphia: Lippincott Williams and
Wilkins, 2010; p 42-107.